Edges in Network
| Network | GSE16446_top500tf - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | ATF5 |
| Upstream (Parents) |
|---|
| (<<) ENO1 → ATF5 |
| (<<) SOX9 → ATF5 |
| (<<) RCAN1 → ATF5 |
| (<<) RUNX3 → ATF5 |
| (<<) TCF7L1 → ATF5 |
| (<<) IRF1 → ATF5 |
| (<<) ZEB1 → ATF5 |
| (<<) HES1 → ATF5 |
| (<<) BATF2 → ATF5 |
| (<<) FOXP1 → ATF5 |
| (<<) TGIF2 → ATF5 |
| (<<) UBN1 → ATF5 |
| (<<) PTTG1 → ATF5 |
| (<<) MYBL2 → ATF5 |
| (<<) ISX → ATF5 |
| (<<) SOLH → ATF5 |
| (<<) ELF4 → ATF5 |
| (<<) PHF5A → ATF5 |
| (<<) SUPT4H1 → ATF5 |
| Downstream (Children) |
|---|
| ATF5 → BNC1 (>>) |
| ATF5 → DMRT2 (>>) |
| ATF5 → ZNF643 (>>) |
| ATF5 → TFDP1 (>>) |
| ATF5 → ETV5 (>>) |
| ATF5 → MTA1 (>>) |
| ATF5 → HOXD10 (>>) |
| ATF5 → TSC22D1 (>>) |
| ATF5 → CCRN4L (>>) |
| ATF5 → GLI2 (>>) |
